SGMO timeline | SGMO Message Board Posts


Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  166833 of 167171  at  8/5/2022 10:02:14 PM  by

spaddy


 In response to msg 162226 by  spaddy
view thread

Re: SGMO timeline

 Below is the timeline since i last posted 8 months ago..
Have to start digging again to make updates since i havent been paying attention.
Maybe biotech winter is finally over and time to pay attention again.
It seems like there have been lots of changes and delays in timeline ( no surprise )
What is happening to GILD CART and CNS programs?- seems i have to start digging though the posts :) 
I see they have been busy printing shares and raising cash to stay alive :) 
 

SGMO timeline

SGMO event timeline update - replying to my timeline if you want to see changes.
Although all events are important for the company, I will highlight the ones I feel will have the most effect on share price ( not coincidentally its human trial data )


Where SGMO is now in trials:
Hemo A- Phase 3 started dosing 3q 2020- clinical hold 4q 2021- > 50% dosed
Fabrys- phase 1 dosing started 3q 2020- dosed 3 cohorts- 5 patients total
Beta Thal- phase 1 -dosed 5 patients phase 1- stopped dosing
Sickle cell- phase 1/2- 4 patients dosed
TxCell T reg for renal transplant- enrolled 1/ dose 1h 2022?
MPS II -dosed to cohort 3 multiple patients- - reboot possible
 
1H 2022
Fabry- data in phase 1 trial
 
2H 2022
GILD- CART IND
IND CNS Tau with Biogen
CART-Reg data in renal transplant patients
Sanofi- sickle data-
Hemo A Pfizer updated phase 3 data
Fabry- renal biopsy data cohort 3
 
2023
Hemo A Pfizer full phase 3 data
Fabry 1 year extended cohort 3 data
Hemo A FDA accelerated filing - Pfizer
CART-Reg IND ( MS vs IBD)
Dose CNS Tau with Biogen
CNS Parkinson's IND with Biogen
CNS Autism IND with Novartis
GILD 2nd CART IND
Sanofi- sickle data
 
2024
Launch Hemo A commercially *
Fabry file for FDA approval and launch



     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 12  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
166841 Re: SGMO timeline 2fingers 23 8/6/2022 10:37:05 AM




Financial Market Data provided by
.
Loading...